Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Neurology 20

Neurology

MedTech News for Medtronic, Penumbra, and Genesis

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Medtronic Launches Infusion Set for Insulin Pumps; Penumbra’s Virtual Reality-Based Rehabilitation System; FDA Approval to Genesis’s Chocolate Touch® Drug-coated Balloon PTA Catheter; FDA Nod to AEYE’s AI-based Autonomous Screening; Alpheus Medical Treats First High-Grade Glioma Brain Cancer Patient with its Proprietary Platform; Karidum’s Next Generation Globe® Pulsed Field System

Medtronic Launches World's First and Only Infusion Set for Insulin Pumps that Doubles Wear Time up to 7 days in the US On November 15, 2022, Medtronic plc, a global leader in healthcare technology, announced the US launch of the Medtronic Extended infusion set, the first and only infusion set labeled for up to 7-day wear. To double the wear time of an infusion set, the Medtronic Extended infusion set employs advanced materials that help reduce insulin preservative loss while maintaining insulin flow and stability. The Medtronic Extended infusion set's innovative design incorporates proprietary technology, such as a new tubing connector, which improves the...

Explore More...

Amyotrophic Lateral Sclerosis Pipeline

Top 10 Most Promising Drugs In The Amyotrophic Lateral Sclerosis Treatment Landscape

Frequently Asked Questions About Epilepsy And Seizures

21 of the most common questions about Epilepsy

Digital Therapeutics

Treating Patients with Software: Digital Therapeutics

recent-pharma-biotech-news-updates-for-astrazeneca-uniqure-csl

AstraZeneca’s COVID-19 vaccine; Type 1 diabetes research updates; FDA nod to Zebra’s X-ray modelling AI; UniQure/CSL haemophilia B gene therapy curbs bleeding in phase 3

KaliVir, Astellas deal; AbCellera IPO; Bayer's CAR-T collabs; NASH therapy

KaliVir, Astellas licensing deal; AbCellera’s IPO; Bayer CAR-T Cell therapy collab with Atara; Aligos, Merck together against NASH

Neuromodulation Devices

Advancements in Neuromodulation

Albireo's PFIC Therapy; Lupin’s Trichomoniasis Drug; Moderna's COVID vaccine; NASH Cocktail Therapy

Albireo Pharma’s PFIC Therapy; Lupin’s Trichomoniasis Oral Drug; Moderna’s Weapon Against COVID; Gilead & Novo Nordisk’s Cocktail Therapy for NASH

Epilepsy Market

Ever-evolving Market Dynamics of Epilepsy – a silver lining!

recent-pharma-biotech-news-updates-for-fosun-biontech-biomarin-Boston-Scientific

Fosun-BioNTech’s COVID-19 vaccine; Multiple Sclerosis research update; Vosoritide nabs FDA review; FDA nods to paclitaxel-coated Ranger balloon for PAD

Burden of Neurodegenerative Disorders

The Growing Burden Of Neurodegenerative Disorders

recent-pharma-news-updates-cyclerion-nimbus-dyno-rayzebio

Cyclerion’s olinciguat flunks sickle cell test; Nimbus nets $60M; Dyno-Roche’s gene therapy pact; RayzeBio debuts with $ 45M to target tumors

recent-pharma-news-and-updates-for-santhera-merck-novartis-scribe

Santhera flunks DMD phase 3; Scribe emerges with $20 M; Merck sells off Osteoarthritis drug to Novartis; Research updates on flu vaccine and glioblastoma

Opioid-overdose-addiction-abuse-epidemic-crisis

How do we curb the Opioid Epidemic?

medical-marijuana-clinical-trials

Conditions Medical Marijuana is Anticipated to be Prescribed in the Offing

recent-pharma-happenings-for-j-j-anokion-bms-roche

J&J ‘s COVID-19 vaccine; Roche, AC Immune’s anti-Tau Alzheimer’s drug; Silverback nets $85 M; Anokion’s deal rides out BMS-Celgene merger; Coronavirus spike protein could inspire vaccine development

Samsung/AZ Deal; Gyroscope’s GT005; Inflazome's Buyout; Abbott's MitraClip4; Grail Buyback

Samsung/AZ Deal; Gyroscope’s Dry AMD Gene Therapy; Inflazome’s Buyout; Abbott’s MitraClip4 EU Approval; Grail Buybacks

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly